Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in covalent drug discovery
Lydia Boike, Nathaniel J. Henning, Daniel K. Nomura
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 881-898
Open Access | Times Cited: 469

Showing 1-25 of 469 citing articles:

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 402
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 144
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114
SwissDock 2024: major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina
Marine Bugnon, Ute F. Röhrig, Mathilde Goullieux, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. W1, pp. W324-W332
Open Access | Times Cited: 93
CavityPlus 2022 Update: An Integrated Platform for Comprehensive Protein Cavity Detection and Property Analyses with User-friendly Tools and Cavity Databases
Shiwei Wang, Juan Xie, Jianfeng Pei, et al.
Journal of Molecular Biology (2023) Vol. 435, Iss. 14, pp. 168141-168141
Closed Access | Times Cited: 57
Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes
Ingo V. Hartung, Joachim Rudolph, Mary M. Mader, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9297-9312
Open Access | Times Cited: 56
Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir
Xiangrui Jiang, Haixia Su, Weijuan Shang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 56
Covalent targeted radioligands potentiate radionuclide therapy
Xi‐Yang Cui, Zhu Li, Ziren Kong, et al.
Nature (2024) Vol. 630, Iss. 8015, pp. 206-213
Closed Access | Times Cited: 49
Targeting the Estrogen Receptor for the Treatment of Breast Cancer: Recent Advances and Challenges
Rohan Kalyan Rej, J. Thomas, Ranjan Kumar Acharyya, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8339-8381
Open Access | Times Cited: 48
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
Laura Hillebrand, Xiaojun Julia Liang, Ricardo Augusto Massarico Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 46
Template-assisted covalent modification of DCAF16 underlies activity of BRD4 molecular glue degraders
Yen-Der Li, W Michelle, Muhammad Murtaza Hassan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 44
Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases
Qian Huang, Yi Ru, Ying‐Li Luo, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 33
Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells
Xizhen Lian, Sumanta Chatterjee, Yehui Sun, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 9, pp. 1409-1417
Closed Access | Times Cited: 28
Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells
Fabian Offensperger, Gary Tin, Miquel Duran‐Frigola, et al.
Science (2024) Vol. 384, Iss. 6694
Closed Access | Times Cited: 23
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability
Mariko Takahashi, Harrison B. Chong, Siwen Zhang, et al.
Cell (2024) Vol. 187, Iss. 10, pp. 2536-2556.e30
Open Access | Times Cited: 20
Targeted Protein Degradation through Recruitment of the CUL4 Complex Adaptor Protein DDB1
Margot Meyers, Sabine Cismoski, Anoohya Panidapu, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 1, pp. 58-68
Open Access | Times Cited: 19
Advancing Ligand Docking through Deep Learning: Challenges and Prospects in Virtual Screening
Xujun Zhang, Chao Shen, Haotian Zhang, et al.
Accounts of Chemical Research (2024) Vol. 57, Iss. 10, pp. 1500-1509
Closed Access | Times Cited: 16
Degraders upgraded: the rise of PROTACs in hematological malignancies
Joshua Casan, John F. Seymour
Blood (2024) Vol. 143, Iss. 13, pp. 1218-1230
Closed Access | Times Cited: 15
Robust proteome profiling of cysteine-reactive fragments using label-free chemoproteomics
George S. Biggs, Emma E. Cawood, Aini Vuorinen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Engineering covalent small molecule–RNA complexes in living cells
Raphael Bereiter, Laurin Flemmich, Kamila Nykiel, et al.
Nature Chemical Biology (2025)
Open Access | Times Cited: 2
The Local Vibrational Mode Theory and Its Place in the Vibrational Spectroscopy Arena
Elfi Kraka, Mateus Quintano, Hunter La Force, et al.
The Journal of Physical Chemistry A (2022) Vol. 126, Iss. 47, pp. 8781-8798
Closed Access | Times Cited: 57
2-Ethynylbenzaldehyde-Based, Lysine-Targeting Irreversible Covalent Inhibitors for Protein Kinases and Nonkinases
Peng Chen, Guanghui Tang, Chengjun Zhu, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 7, pp. 3844-3849
Closed Access | Times Cited: 31
Small-molecule probes from bench to bedside: advancing molecular analysis of drug–target interactions toward precision medicine
Sijun Pan, Aixiang Ding, Yisi Li, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 16, pp. 5706-5743
Closed Access | Times Cited: 29
Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology
Maud B. A. van der Kleij, Niels A.D. Guchelaar, Ron H.J. Mathijssen, et al.
Clinical Pharmacokinetics (2023) Vol. 62, Iss. 10, pp. 1333-1364
Open Access | Times Cited: 28
Thiomethyltetrazines Are Reversible Covalent Cysteine Warheads Whose Dynamic Behavior can be “Switched Off” via Bioorthogonal Chemistry Inside Live Cells
Amanda Tallon, Yingrong Xu, Graham M. West, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 29, pp. 16069-16080
Closed Access | Times Cited: 25
Page 1 - Next Page

Scroll to top